We are live on ! Find out more
PVCT

PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT

Delisted

PVCT was delisted on the 13th of October, 2016.

Back to rankings

3 hedge funds and large institutions have $6K invested in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in 2020 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3 → 3 (0)

14% less capital invested

Capital invested by funds: $7K → $6K (-$1K)

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HFBOT
1
Home Federal Bank of Tennessee
Tennessee
$5K – – –
ACM
2
Academy Capital Management
Texas
$1K – – –

PVCT Hedge Fund Activity: Q1 2020 in Review

3 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) for Q1 2020, worth a combined $6K — down 14% from $7K a quarter earlier.

Fund positioning in PVCT was balanced in Q1 2020: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 3 institutional investors held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) as of Q1 2020, unchanged from Q4 2019.
  • Funds reported $6K of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) stock for Q1 2020, down 14% quarter-over-quarter.
  • 0 funds opened new PROVECTUS BIOPHARMACEUTICALS, INC. (DE) positions in Q1 2020 and 0 closed out.

Based on aggregated 13F filings for Q1 2020.